Zealand Pharma A/S
Zealand Pharma A/S (ZLDPF) Stock Competitors & Peer Comparison
See (ZLDPF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZLDPF | $57.08 | -5.53% | 4B | 3.93 | $14.50 | N/A |
| NONOF | $38.25 | -4.76% | 169.9B | 10.45 | $3.66 | +4.48% |
| CSLLY | $51.60 | -0.98% | 99.1B | 16.61 | $3.08 | +2.67% |
| UCBJF | $307.21 | -9.17% | 62.4B | 40.27 | $8.15 | +0.48% |
| UCBJY | $158.89 | -0.29% | 60.6B | 39.31 | $4.06 | +0.49% |
| ARGNF | $814.94 | -2.87% | 50.4B | 34.84 | $23.39 | N/A |
| CMXHF | $98.99 | -4.29% | 47.7B | 15.95 | $6.17 | +2.97% |
| WXIBF | $5.16 | -1.90% | 21.4B | 36.96 | $0.14 | N/A |
| WXXWY | $10.61 | +1.05% | 21.2B | 37.29 | $0.28 | N/A |
| IVBXF | $11.28 | -1.05% | 19.4B | 112.80 | $0.10 | N/A |
Stock Comparison
ZLDPF vs NONOF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, NONOF has a market cap of 169.9B. Regarding current trading prices, ZLDPF is priced at $57.08, while NONOF trades at $38.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas NONOF's P/E ratio is 10.45. In terms of profitability, ZLDPF's ROE is +0.48%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, ZLDPF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check NONOF's competition here
ZLDPF vs CSLLY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CSLLY has a market cap of 99.1B. Regarding current trading prices, ZLDPF is priced at $57.08, while CSLLY trades at $51.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CSLLY's P/E ratio is 16.61. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, ZLDPF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CSLLY's competition here
ZLDPF vs UCBJF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, UCBJF has a market cap of 62.4B. Regarding current trading prices, ZLDPF is priced at $57.08, while UCBJF trades at $307.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas UCBJF's P/E ratio is 40.27. In terms of profitability, ZLDPF's ROE is +0.48%, compared to UCBJF's ROE of +0.14%. Regarding short-term risk, ZLDPF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check UCBJF's competition here
ZLDPF vs UCBJY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, UCBJY has a market cap of 60.6B. Regarding current trading prices, ZLDPF is priced at $57.08, while UCBJY trades at $158.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas UCBJY's P/E ratio is 39.31. In terms of profitability, ZLDPF's ROE is +0.48%, compared to UCBJY's ROE of +0.14%. Regarding short-term risk, ZLDPF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check UCBJY's competition here
ZLDPF vs ARGNF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ARGNF has a market cap of 50.4B. Regarding current trading prices, ZLDPF is priced at $57.08, while ARGNF trades at $814.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ARGNF's P/E ratio is 34.84. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ARGNF's ROE of +0.22%. Regarding short-term risk, ZLDPF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ARGNF's competition here
ZLDPF vs CMXHF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CMXHF has a market cap of 47.7B. Regarding current trading prices, ZLDPF is priced at $57.08, while CMXHF trades at $98.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CMXHF's P/E ratio is 15.95. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, ZLDPF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CMXHF's competition here
ZLDPF vs WXIBF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, WXIBF has a market cap of 21.4B. Regarding current trading prices, ZLDPF is priced at $57.08, while WXIBF trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas WXIBF's P/E ratio is 36.96. In terms of profitability, ZLDPF's ROE is +0.48%, compared to WXIBF's ROE of +0.10%. Regarding short-term risk, ZLDPF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check WXIBF's competition here
ZLDPF vs WXXWY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, WXXWY has a market cap of 21.2B. Regarding current trading prices, ZLDPF is priced at $57.08, while WXXWY trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas WXXWY's P/E ratio is 37.29. In terms of profitability, ZLDPF's ROE is +0.48%, compared to WXXWY's ROE of +0.10%. Regarding short-term risk, ZLDPF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check WXXWY's competition here
ZLDPF vs IVBXF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, IVBXF has a market cap of 19.4B. Regarding current trading prices, ZLDPF is priced at $57.08, while IVBXF trades at $11.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas IVBXF's P/E ratio is 112.80. In terms of profitability, ZLDPF's ROE is +0.48%, compared to IVBXF's ROE of +0.08%. Regarding short-term risk, ZLDPF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check IVBXF's competition here
ZLDPF vs GNMSF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, GNMSF has a market cap of 17.9B. Regarding current trading prices, ZLDPF is priced at $57.08, while GNMSF trades at $290.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas GNMSF's P/E ratio is 12.70. In terms of profitability, ZLDPF's ROE is +0.48%, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, ZLDPF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check GNMSF's competition here
ZLDPF vs SBMFF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SBMFF has a market cap of 15B. Regarding current trading prices, ZLDPF is priced at $57.08, while SBMFF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SBMFF's P/E ratio is 28.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SBMFF's ROE of +0.12%. Regarding short-term risk, ZLDPF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SBMFF's competition here
ZLDPF vs SBHMY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, ZLDPF is priced at $57.08, while SBHMY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SBHMY's P/E ratio is 25.22. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SBHMY's ROE of +0.12%. Regarding short-term risk, ZLDPF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SBHMY's competition here
ZLDPF vs AAVXF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, AAVXF has a market cap of 9.9B. Regarding current trading prices, ZLDPF is priced at $57.08, while AAVXF trades at $125.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas AAVXF's P/E ratio is -24.03. In terms of profitability, ZLDPF's ROE is +0.48%, compared to AAVXF's ROE of +50.78%. Regarding short-term risk, ZLDPF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check AAVXF's competition here
ZLDPF vs BRRGF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, ZLDPF is priced at $57.08, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BRRGF's ROE of -1.05%. Regarding short-term risk, ZLDPF is more volatile compared to BRRGF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BRRGF's competition here
ZLDPF vs ODTC Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, ZLDPF is priced at $57.08, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ODTC's P/E ratio is 1.07. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ZLDPF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ODTC's competition here
ZLDPF vs AKBLF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, AKBLF has a market cap of 7.3B. Regarding current trading prices, ZLDPF is priced at $57.08, while AKBLF trades at $36.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas AKBLF's P/E ratio is 45.70. In terms of profitability, ZLDPF's ROE is +0.48%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, ZLDPF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check AKBLF's competition here
ZLDPF vs TRSBF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, TRSBF has a market cap of 6.2B. Regarding current trading prices, ZLDPF is priced at $57.08, while TRSBF trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas TRSBF's P/E ratio is 18.71. In terms of profitability, ZLDPF's ROE is +0.48%, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, ZLDPF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check TRSBF's competition here
ZLDPF vs REGMF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, REGMF has a market cap of 5.9B. Regarding current trading prices, ZLDPF is priced at $57.08, while REGMF trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas REGMF's P/E ratio is -33.71. In terms of profitability, ZLDPF's ROE is +0.48%, compared to REGMF's ROE of -0.45%. Regarding short-term risk, ZLDPF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check REGMF's competition here
ZLDPF vs ABCZF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, ZLDPF is priced at $57.08, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, ZLDPF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ABCZF's competition here
ZLDPF vs LABFF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ZLDPF is priced at $57.08, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ZLDPF's ROE is +0.48%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, ZLDPF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check LABFF's competition here
ZLDPF vs SHJBF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SHJBF has a market cap of 4.1B. Regarding current trading prices, ZLDPF is priced at $57.08, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SHJBF's P/E ratio is -20.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SHJBF's ROE of -0.16%. Regarding short-term risk, ZLDPF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SHJBF's competition here
ZLDPF vs GNNSF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, GNNSF has a market cap of 3.8B. Regarding current trading prices, ZLDPF is priced at $57.08, while GNNSF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas GNNSF's P/E ratio is -43.75. In terms of profitability, ZLDPF's ROE is +0.48%, compared to GNNSF's ROE of +0.71%. Regarding short-term risk, ZLDPF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check GNNSF's competition here
ZLDPF vs CAMRF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CAMRF has a market cap of 3.5B. Regarding current trading prices, ZLDPF is priced at $57.08, while CAMRF trades at $58.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CAMRF's P/E ratio is 42.34. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, ZLDPF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CAMRF's competition here
ZLDPF vs BRCTF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BRCTF has a market cap of 3.4B. Regarding current trading prices, ZLDPF is priced at $57.08, while BRCTF trades at $38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BRCTF's P/E ratio is 29.92. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, ZLDPF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BRCTF's competition here
ZLDPF vs ASPHF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, ZLDPF is priced at $57.08, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ASPHF's ROE of -1.40%. Regarding short-term risk, ZLDPF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ASPHF's competition here
ZLDPF vs MPSYF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, ZLDPF is priced at $57.08, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ZLDPF's ROE is +0.48%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, ZLDPF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check MPSYF's competition here
ZLDPF vs GENSF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, GENSF has a market cap of 2.5B. Regarding current trading prices, ZLDPF is priced at $57.08, while GENSF trades at $37.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas GENSF's P/E ratio is 95.51. In terms of profitability, ZLDPF's ROE is +0.48%, compared to GENSF's ROE of +0.04%. Regarding short-term risk, ZLDPF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check GENSF's competition here
ZLDPF vs BVNRY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BVNRY has a market cap of 2.4B. Regarding current trading prices, ZLDPF is priced at $57.08, while BVNRY trades at $10.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BVNRY's P/E ratio is 6.30. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BVNRY's ROE of +0.20%. Regarding short-term risk, ZLDPF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BVNRY's competition here
ZLDPF vs BVNKF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, ZLDPF is priced at $57.08, while BVNKF trades at $30.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BVNKF's P/E ratio is 6.24. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BVNKF's ROE of +0.20%. Regarding short-term risk, ZLDPF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BVNKF's competition here
ZLDPF vs INCPF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, ZLDPF is priced at $57.08, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas INCPF's P/E ratio is -77.50. In terms of profitability, ZLDPF's ROE is +0.48%, compared to INCPF's ROE of -0.03%. Regarding short-term risk, ZLDPF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check INCPF's competition here
ZLDPF vs GLPGF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, ZLDPF is priced at $57.08, while GLPGF trades at $34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas GLPGF's P/E ratio is -4.24. In terms of profitability, ZLDPF's ROE is +0.48%, compared to GLPGF's ROE of -0.16%. Regarding short-term risk, ZLDPF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check GLPGF's competition here
ZLDPF vs ASCLF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ASCLF has a market cap of 2.1B. Regarding current trading prices, ZLDPF is priced at $57.08, while ASCLF trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ASCLF's P/E ratio is -53.87. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, ZLDPF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ASCLF's competition here
ZLDPF vs MEOBF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, ZLDPF is priced at $57.08, while MEOBF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas MEOBF's P/E ratio is -15.90. In terms of profitability, ZLDPF's ROE is +0.48%, compared to MEOBF's ROE of -0.19%. Regarding short-term risk, ZLDPF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check MEOBF's competition here
ZLDPF vs TLPPF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, TLPPF has a market cap of 2B. Regarding current trading prices, ZLDPF is priced at $57.08, while TLPPF trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas TLPPF's P/E ratio is 302.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, ZLDPF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check TLPPF's competition here
ZLDPF vs ONTTF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, ZLDPF is priced at $57.08, while ONTTF trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ONTTF's P/E ratio is -9.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ONTTF's ROE of -0.26%. Regarding short-term risk, ZLDPF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ONTTF's competition here
ZLDPF vs BIESF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, ZLDPF is priced at $57.08, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BIESF's P/E ratio is -44.44. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BIESF's ROE of -0.07%. Regarding short-term risk, ZLDPF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BIESF's competition here
ZLDPF vs PHMMF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, PHMMF has a market cap of 1.5B. Regarding current trading prices, ZLDPF is priced at $57.08, while PHMMF trades at $88.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas PHMMF's P/E ratio is 38.57. In terms of profitability, ZLDPF's ROE is +0.48%, compared to PHMMF's ROE of +0.17%. Regarding short-term risk, ZLDPF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check PHMMF's competition here
ZLDPF vs HBMHF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, ZLDPF is priced at $57.08, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, ZLDPF's ROE is +0.48%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, ZLDPF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check HBMHF's competition here
ZLDPF vs SNBIF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, ZLDPF is priced at $57.08, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SNBIF's ROE of -2.53%. Regarding short-term risk, ZLDPF is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SNBIF's competition here
ZLDPF vs IDRSF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, IDRSF has a market cap of 1.3B. Regarding current trading prices, ZLDPF is priced at $57.08, while IDRSF trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas IDRSF's P/E ratio is -6.35. In terms of profitability, ZLDPF's ROE is +0.48%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, ZLDPF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check IDRSF's competition here
ZLDPF vs CSPHF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CSPHF has a market cap of 1.3B. Regarding current trading prices, ZLDPF is priced at $57.08, while CSPHF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CSPHF's P/E ratio is -21.53. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CSPHF's ROE of -0.71%. Regarding short-term risk, ZLDPF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CSPHF's competition here
ZLDPF vs CSBTF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, ZLDPF is priced at $57.08, while CSBTF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CSBTF's P/E ratio is -160.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CSBTF's ROE of -0.08%. Regarding short-term risk, ZLDPF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CSBTF's competition here
ZLDPF vs MDCLF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, ZLDPF is priced at $57.08, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, ZLDPF's ROE is +0.48%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, ZLDPF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check MDCLF's competition here
ZLDPF vs PPTDF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, PPTDF has a market cap of 1.1B. Regarding current trading prices, ZLDPF is priced at $57.08, while PPTDF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas PPTDF's P/E ratio is -46.58. In terms of profitability, ZLDPF's ROE is +0.48%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, ZLDPF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check PPTDF's competition here
ZLDPF vs PHGUF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, PHGUF has a market cap of 1.1B. Regarding current trading prices, ZLDPF is priced at $57.08, while PHGUF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas PHGUF's P/E ratio is -160.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to PHGUF's ROE of +0.00%. Regarding short-term risk, ZLDPF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check PHGUF's competition here
ZLDPF vs NURPF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, ZLDPF is priced at $57.08, while NURPF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas NURPF's P/E ratio is 10.52. In terms of profitability, ZLDPF's ROE is +0.48%, compared to NURPF's ROE of +0.43%. Regarding short-term risk, ZLDPF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check NURPF's competition here
ZLDPF vs INRLF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, INRLF has a market cap of 1B. Regarding current trading prices, ZLDPF is priced at $57.08, while INRLF trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas INRLF's P/E ratio is -7.66. In terms of profitability, ZLDPF's ROE is +0.48%, compared to INRLF's ROE of -0.59%. Regarding short-term risk, ZLDPF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check INRLF's competition here
ZLDPF vs BTTAY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, ZLDPF is priced at $57.08, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, ZLDPF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BTTAY's competition here
ZLDPF vs TKBIF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, ZLDPF is priced at $57.08, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas TKBIF's P/E ratio is -21.47. In terms of profitability, ZLDPF's ROE is +0.48%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ZLDPF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check TKBIF's competition here
ZLDPF vs BPMUF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, ZLDPF is priced at $57.08, while BPMUF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, ZLDPF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BPMUF's competition here
ZLDPF vs VBIZF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, ZLDPF is priced at $57.08, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, ZLDPF's ROE is +0.48%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, ZLDPF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check VBIZF's competition here
ZLDPF vs IVEVF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, IVEVF has a market cap of 617.4M. Regarding current trading prices, ZLDPF is priced at $57.08, while IVEVF trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas IVEVF's P/E ratio is -1.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, ZLDPF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check IVEVF's competition here
ZLDPF vs CKDXF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, ZLDPF is priced at $57.08, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, ZLDPF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CKDXF's competition here
ZLDPF vs SOLTF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SOLTF has a market cap of 492.3M. Regarding current trading prices, ZLDPF is priced at $57.08, while SOLTF trades at $5.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SOLTF's P/E ratio is -6.04. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, ZLDPF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SOLTF's competition here
ZLDPF vs GNFTF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, GNFTF has a market cap of 461M. Regarding current trading prices, ZLDPF is priced at $57.08, while GNFTF trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas GNFTF's P/E ratio is -9.95. In terms of profitability, ZLDPF's ROE is +0.48%, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, ZLDPF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check GNFTF's competition here
ZLDPF vs RAONF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, ZLDPF is priced at $57.08, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas RAONF's P/E ratio is -43.33. In terms of profitability, ZLDPF's ROE is +0.48%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, ZLDPF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check RAONF's competition here
ZLDPF vs GNFTY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, GNFTY has a market cap of 445.3M. Regarding current trading prices, ZLDPF is priced at $57.08, while GNFTY trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas GNFTY's P/E ratio is -9.57. In terms of profitability, ZLDPF's ROE is +0.48%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, ZLDPF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check GNFTY's competition here
ZLDPF vs TBGNF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, ZLDPF is priced at $57.08, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ZLDPF's ROE is +0.48%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, ZLDPF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check TBGNF's competition here
ZLDPF vs CLVLF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, ZLDPF is priced at $57.08, while CLVLF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CLVLF's ROE of +0.16%. Regarding short-term risk, ZLDPF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CLVLF's competition here
ZLDPF vs CLVLY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CLVLY has a market cap of 423.7M. Regarding current trading prices, ZLDPF is priced at $57.08, while CLVLY trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CLVLY's P/E ratio is 16.55. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CLVLY's ROE of +0.16%. Regarding short-term risk, ZLDPF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CLVLY's competition here
ZLDPF vs PTCHF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, PTCHF has a market cap of 410.4M. Regarding current trading prices, ZLDPF is priced at $57.08, while PTCHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas PTCHF's P/E ratio is 9.99. In terms of profitability, ZLDPF's ROE is +0.48%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, ZLDPF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check PTCHF's competition here
ZLDPF vs PRRUF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, PRRUF has a market cap of 368M. Regarding current trading prices, ZLDPF is priced at $57.08, while PRRUF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas PRRUF's P/E ratio is -8.33. In terms of profitability, ZLDPF's ROE is +0.48%, compared to PRRUF's ROE of -0.27%. Regarding short-term risk, ZLDPF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check PRRUF's competition here
ZLDPF vs NWBO Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, NWBO has a market cap of 360.1M. Regarding current trading prices, ZLDPF is priced at $57.08, while NWBO trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas NWBO's P/E ratio is -3.90. In terms of profitability, ZLDPF's ROE is +0.48%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, ZLDPF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check NWBO's competition here
ZLDPF vs AVCTF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, AVCTF has a market cap of 349.9M. Regarding current trading prices, ZLDPF is priced at $57.08, while AVCTF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas AVCTF's P/E ratio is -5.33. In terms of profitability, ZLDPF's ROE is +0.48%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, ZLDPF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check AVCTF's competition here
ZLDPF vs NGENF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, NGENF has a market cap of 333.5M. Regarding current trading prices, ZLDPF is priced at $57.08, while NGENF trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas NGENF's P/E ratio is -16.19. In terms of profitability, ZLDPF's ROE is +0.48%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, ZLDPF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check NGENF's competition here
ZLDPF vs CYDY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CYDY has a market cap of 328.5M. Regarding current trading prices, ZLDPF is priced at $57.08, while CYDY trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CYDY's P/E ratio is -8.62. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CYDY's ROE of +0.38%. Regarding short-term risk, ZLDPF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check CYDY's competition here
ZLDPF vs CMVLF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CMVLF has a market cap of 325.5M. Regarding current trading prices, ZLDPF is priced at $57.08, while CMVLF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CMVLF's P/E ratio is -13.64. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CMVLF's ROE of -0.32%. Regarding short-term risk, ZLDPF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CMVLF's competition here
ZLDPF vs SPHDF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SPHDF has a market cap of 294.9M. Regarding current trading prices, ZLDPF is priced at $57.08, while SPHDF trades at $21.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SPHDF's P/E ratio is -3.03. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, ZLDPF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SPHDF's competition here
ZLDPF vs PBBIF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, ZLDPF is priced at $57.08, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ZLDPF's ROE is +0.48%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ZLDPF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check PBBIF's competition here
ZLDPF vs FGHQF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, FGHQF has a market cap of 283.9M. Regarding current trading prices, ZLDPF is priced at $57.08, while FGHQF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas FGHQF's P/E ratio is 14.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, ZLDPF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check FGHQF's competition here
ZLDPF vs ORYZF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ORYZF has a market cap of 283.9M. Regarding current trading prices, ZLDPF is priced at $57.08, while ORYZF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ORYZF's P/E ratio is -90.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, ZLDPF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ORYZF's competition here
ZLDPF vs ORPOF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, ZLDPF is priced at $57.08, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ORPOF's ROE of N/A. Regarding short-term risk, ZLDPF is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ORPOF's competition here
ZLDPF vs HNSBF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, HNSBF has a market cap of 246.6M. Regarding current trading prices, ZLDPF is priced at $57.08, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas HNSBF's P/E ratio is -2.88. In terms of profitability, ZLDPF's ROE is +0.48%, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, ZLDPF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check HNSBF's competition here
ZLDPF vs HLOSF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, HLOSF has a market cap of 243M. Regarding current trading prices, ZLDPF is priced at $57.08, while HLOSF trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas HLOSF's P/E ratio is -12.35. In terms of profitability, ZLDPF's ROE is +0.48%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, ZLDPF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check HLOSF's competition here
ZLDPF vs NWPHF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, NWPHF has a market cap of 239.5M. Regarding current trading prices, ZLDPF is priced at $57.08, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ZLDPF's ROE is +0.48%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, ZLDPF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check NWPHF's competition here
ZLDPF vs SLNCF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, ZLDPF is priced at $57.08, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SLNCF's P/E ratio is -3.56. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SLNCF's ROE of -1.47%. Regarding short-term risk, ZLDPF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SLNCF's competition here
ZLDPF vs CAIHF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, ZLDPF is priced at $57.08, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, ZLDPF's ROE is +0.48%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, ZLDPF is more volatile compared to CAIHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check CAIHF's competition here
ZLDPF vs BOVNF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, ZLDPF is priced at $57.08, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BOVNF's ROE of -0.41%. Regarding short-term risk, ZLDPF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BOVNF's competition here
ZLDPF vs FPHAF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, ZLDPF is priced at $57.08, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ZLDPF's ROE is +0.48%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, ZLDPF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check FPHAF's competition here
ZLDPF vs SCNLF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SCNLF has a market cap of 189.4M. Regarding current trading prices, ZLDPF is priced at $57.08, while SCNLF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SCNLF's P/E ratio is -18.25. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, ZLDPF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SCNLF's competition here
ZLDPF vs IPHYF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, IPHYF has a market cap of 186.5M. Regarding current trading prices, ZLDPF is priced at $57.08, while IPHYF trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas IPHYF's P/E ratio is -3.06. In terms of profitability, ZLDPF's ROE is +0.48%, compared to IPHYF's ROE of -6.59%. Regarding short-term risk, ZLDPF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check IPHYF's competition here
ZLDPF vs KNTPF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, KNTPF has a market cap of 184M. Regarding current trading prices, ZLDPF is priced at $57.08, while KNTPF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas KNTPF's P/E ratio is -6.54. In terms of profitability, ZLDPF's ROE is +0.48%, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, ZLDPF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check KNTPF's competition here
ZLDPF vs MSCLF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, MSCLF has a market cap of 174.1M. Regarding current trading prices, ZLDPF is priced at $57.08, while MSCLF trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas MSCLF's P/E ratio is 4.38. In terms of profitability, ZLDPF's ROE is +0.48%, compared to MSCLF's ROE of -0.52%. Regarding short-term risk, ZLDPF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check MSCLF's competition here
ZLDPF vs ADOCY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, ZLDPF is priced at $57.08, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, ZLDPF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ADOCY's competition here
ZLDPF vs SPHRF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SPHRF has a market cap of 163.8M. Regarding current trading prices, ZLDPF is priced at $57.08, while SPHRF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SPHRF's P/E ratio is -39.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, ZLDPF is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SPHRF's competition here
ZLDPF vs BBIXF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BBIXF has a market cap of 157.7M. Regarding current trading prices, ZLDPF is priced at $57.08, while BBIXF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BBIXF's P/E ratio is -13.50. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, ZLDPF is more volatile compared to BBIXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BBIXF's competition here
ZLDPF vs SPHRY Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, SPHRY has a market cap of 142.8M. Regarding current trading prices, ZLDPF is priced at $57.08, while SPHRY trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas SPHRY's P/E ratio is -56.67. In terms of profitability, ZLDPF's ROE is +0.48%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, ZLDPF is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check SPHRY's competition here
ZLDPF vs AMGXF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, AMGXF has a market cap of 139.1M. Regarding current trading prices, ZLDPF is priced at $57.08, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ZLDPF's ROE is +0.48%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, ZLDPF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check AMGXF's competition here
ZLDPF vs NDTP Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, NDTP has a market cap of 136M. Regarding current trading prices, ZLDPF is priced at $57.08, while NDTP trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas NDTP's P/E ratio is -2.66. In terms of profitability, ZLDPF's ROE is +0.48%, compared to NDTP's ROE of -0.24%. Regarding short-term risk, ZLDPF is less volatile compared to NDTP. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check NDTP's competition here
ZLDPF vs BRIBF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, ZLDPF is priced at $57.08, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas BRIBF's P/E ratio is -2.35. In terms of profitability, ZLDPF's ROE is +0.48%, compared to BRIBF's ROE of -0.07%. Regarding short-term risk, ZLDPF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check BRIBF's competition here
ZLDPF vs HBPCF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, ZLDPF is priced at $57.08, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, ZLDPF's ROE is +0.48%, compared to HBPCF's ROE of -0.65%. Regarding short-term risk, ZLDPF is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check HBPCF's competition here
ZLDPF vs TRGNF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, ZLDPF is priced at $57.08, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, ZLDPF's ROE is +0.48%, compared to TRGNF's ROE of -6.34%. Regarding short-term risk, ZLDPF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check TRGNF's competition here
ZLDPF vs MLLCF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, MLLCF has a market cap of 130.9M. Regarding current trading prices, ZLDPF is priced at $57.08, while MLLCF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas MLLCF's P/E ratio is -1.67. In terms of profitability, ZLDPF's ROE is +0.48%, compared to MLLCF's ROE of -0.51%. Regarding short-term risk, ZLDPF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check MLLCF's competition here
ZLDPF vs JWCTF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, JWCTF has a market cap of 127.5M. Regarding current trading prices, ZLDPF is priced at $57.08, while JWCTF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, ZLDPF's ROE is +0.48%, compared to JWCTF's ROE of -0.59%. Regarding short-term risk, ZLDPF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check JWCTF's competition here
ZLDPF vs AAPGV Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, ZLDPF is priced at $57.08, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ZLDPF's ROE is +0.48%, compared to AAPGV's ROE of -2.49%. Regarding short-term risk, ZLDPF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check AAPGV's competition here
ZLDPF vs PSTTF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, ZLDPF is priced at $57.08, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ZLDPF's ROE is +0.48%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ZLDPF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check PSTTF's competition here
ZLDPF vs PRNAF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, PRNAF has a market cap of 109.8M. Regarding current trading prices, ZLDPF is priced at $57.08, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas PRNAF's P/E ratio is -1.01. In terms of profitability, ZLDPF's ROE is +0.48%, compared to PRNAF's ROE of -0.38%. Regarding short-term risk, ZLDPF is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check PRNAF's competition here
ZLDPF vs EPRXF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, ZLDPF is priced at $57.08, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ZLDPF's ROE is +0.48%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, ZLDPF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDPF.Check EPRXF's competition here
ZLDPF vs ATGGF Comparison February 2026
ZLDPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDPF stands at 4B. In comparison, ATGGF has a market cap of 107.7M. Regarding current trading prices, ZLDPF is priced at $57.08, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDPF currently has a P/E ratio of 3.93, whereas ATGGF's P/E ratio is N/A. In terms of profitability, ZLDPF's ROE is +0.48%, compared to ATGGF's ROE of -0.70%. Regarding short-term risk, ZLDPF is more volatile compared to ATGGF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDPF.Check ATGGF's competition here